Denali Therapeutics Inc (DNLI)
15.73
-0.36
(-2.24%)
USD |
NASDAQ |
Apr 24, 13:56
Denali Therapeutics Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | 340.81M |
| June 30, 2023 | 343.11M |
| March 31, 2023 | 101.46M |
| December 31, 2022 | 108.46M |
| September 30, 2022 | 110.69M |
| June 30, 2022 | 112.42M |
| March 31, 2022 | 82.88M |
| December 31, 2021 | 48.66M |
| September 30, 2021 | 352.96M |
| June 30, 2021 | 357.07M |
| Date | Value |
|---|---|
| March 31, 2021 | 339.98M |
| December 31, 2020 | 335.66M |
| September 30, 2020 | 23.52M |
| June 30, 2020 | 27.73M |
| March 31, 2020 | 26.08M |
| December 31, 2019 | 26.68M |
| September 30, 2019 | 147.68M |
| June 30, 2019 | 135.27M |
| March 31, 2019 | 132.72M |
| December 31, 2018 | 129.16M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
23.52M
Minimum
Sep 2020
357.07M
Maximum
Jun 2021
167.84M
Average
111.56M
Median
Revenue (TTM) Benchmarks
| Halozyme Therapeutics Inc | 829.25M |
| AIM ImmunoTech Inc | 0.202M |
| Perspective Therapeutics Inc | 0.00 |
| Protalix BioTherapeutics Inc | 65.49M |
| Armata Pharmaceuticals Inc | -- |